Ltr Pharma Limited has released a press release.
SPONTAN Phase II Final Results
Earlier from Ltr Pharma
- FY26 Results Announcement
- SPONTAN Real-World Study Reports 93% Response
- LTR Executes U.S. Commercial Agreement with Strive
- LTR Executes Definitive U.S. Commercial Agreement with Shed
